Stephen Taub

Latest Articles

2017-06-alpha-stephen-taub-ken-griffin-citadel-main.jpg

Ken Griffin’s Citadel Posts Strong Gains in July

Stephen Taub August 8, 2017

Perry Partners Alum’s Cadian Capital Emerges as Top Long-Short Player This Year

Stephen Taub August 7, 2017

Surging Tesla Is the Most Shorted U.S. Stock

Stephen Taub August 3, 2017

2017-07-alpha-stephen-taub-paul-singer-elliott-management-small.jpg

At Athenahealth, Elliott’s Gain is Greenlight’s Nightmare

Stephen Taub August 2, 2017

JANA Sees Boost From Latest Activist Position

Stephen Taub August 2, 2017

2017-07-alpha-stephen-taub-christopher-hohn-tci-small.jpg

Chris Hohn’s TCI Continues to Top Activist Funds

Stephen Taub July 28, 2017

2017-07-alpha-stephen-taub-mick-mcguire-buffalo-wild-wings-small.jpg

As Buffalo Wild Wings Sinks, Marcato Suffers

Stephen Taub July 28, 2017

2017-07-alpha-stephen-taub-jonathan-auerbach-hound-small.jpg

Tiger Seed Hound Partners is Back on Track

Stephen Taub July 26, 2017

2017-07-alpha-stephen-taub-michael-hintze-cqs-small.jpg

CQS Sees Opportunities in Credit, Equities

Stephen Taub July 26, 2017

2017-07-alpha-stephen-taub-bill-ackman-pershing-small.jpg

Ackman’s Pershing Square Raising Money for a New Fund

Stephen Taub July 24, 2017

2017-07-alpha-stephen-taub-philippe-laffont-coatue-management-newsletter.jpg

Laffont’s Coatue Remains a Top Performer in 2017

Stephen Taub July 21, 2017

2017-07-alpha-stephen-taub-viking-andreas-halvorsen-small.jpg

How Viking’s Return of $8 Billion Is Impacting Its Portfolio

Stephen Taub July 20, 2017

2017-07-alpha-stephen-taub-lakewood-capital-management-small.jpg

Lakewood’s Bozza Identifies Two New Short Positions

Stephen Taub July 20, 2017

Balyasny to Sharply Ramp up Its Quant Strategy

Stephen Taub July 19, 2017

2017-07-alpha-stephen-taub-seth-klarman-baupost-group-small.jpg

Seth Klarman’s Baupost Warns About the Risks of Low Volatility

Stephen Taub July 18, 2017

2017-07-alpha-stephen-taub-lee-ainslie-maverick-capital-small.jpg

Shorting Has Hurt Some Long-Short Funds More Than Others

Stephen Taub July 17, 2017

2017-07-alpha-stephen-taub-value-act-valeant-pharmaceuticals-small.jpg

Jeffrey Ubben’s ValueAct Continues to Surge Despite its Valeant Stake

Stephen Taub July 14, 2017

2017-07-alpha-stephen-taub-ken-griffin-citadel-small.jpg

Multistrat Firms Mostly Muddle Along

Stephen Taub July 13, 2017

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

release/4.13.00 build:2025-12-17 Login